About IBIO, INC.
iBio is a biotechnology company focused on developing next-generation therapies for cardiometabolic diseases using an AI-integrated platform to discover precision antibodies for challenging targets. The company aims to address treatment gaps by creating safer and more effective options for patients.
AI-assisted platform for antibody discoveryEpitope Engineering for pinpoint precisionStableHu™ Antibody Optimization for speed and developabilityIntegration of AI with experimental biologyDevelopment of antibodies for hard-to-drug targets
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to IBIO, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.